| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,105 |
14,984 |
$1.51M |
| 99199 |
Unlisted special service, procedure or report |
130,764 |
61,259 |
$615K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,354 |
3,726 |
$420K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,334 |
2,715 |
$295K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,741 |
4,130 |
$286K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,297 |
1,925 |
$212K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,649 |
7,243 |
$161K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,890 |
4,123 |
$147K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,250 |
1,987 |
$101K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,482 |
8,186 |
$86K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,748 |
2,408 |
$78K |
| 99401 |
|
1,790 |
1,474 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
221 |
163 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
149 |
142 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,116 |
521 |
$15K |
| 96127 |
|
3,095 |
2,531 |
$11K |
| 90474 |
|
307 |
290 |
$6K |
| 92551 |
|
6,049 |
4,931 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
72 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
262 |
251 |
$3K |
| 83655 |
|
228 |
193 |
$3K |
| D0145 |
Oral evaluation for a patient under three years of age |
118 |
85 |
$3K |
| 90686 |
|
3,131 |
2,578 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
40 |
29 |
$2K |
| 99173 |
|
6,992 |
5,746 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
96 |
76 |
$2K |
| 0072A |
|
26 |
24 |
$2K |
| 87807 |
|
78 |
56 |
$936.67 |
| 0071A |
|
15 |
13 |
$878.14 |
| D1206 |
Topical application of fluoride varnish |
49 |
40 |
$743.07 |
| 96160 |
|
99 |
52 |
$362.75 |
| 96161 |
|
104 |
51 |
$351.48 |
| 99050 |
|
23 |
12 |
$291.28 |
| 85018 |
|
85 |
57 |
$178.26 |
| 81002 |
|
58 |
39 |
$160.72 |
| 90633 |
|
264 |
235 |
$96.66 |
| 90647 |
|
1,010 |
871 |
$28.96 |
| 90670 |
|
2,176 |
1,869 |
$0.00 |
| 90685 |
|
231 |
227 |
$0.00 |
| 90681 |
|
230 |
205 |
$0.00 |
| 90710 |
|
213 |
180 |
$0.00 |
| 90461 |
|
170 |
162 |
$0.00 |
| 99072 |
|
82 |
78 |
$0.00 |
| 91311 |
|
21 |
12 |
$0.00 |
| 90723 |
|
1,091 |
963 |
$0.00 |
| 99000 |
|
1,328 |
1,022 |
$0.00 |
| 90680 |
|
124 |
121 |
$0.00 |
| 90656 |
|
224 |
204 |
$0.00 |
| 91307 |
|
92 |
84 |
$0.00 |
| 94760 |
|
13 |
13 |
$0.00 |
| 90677 |
|
121 |
117 |
$0.00 |
| 90696 |
|
15 |
12 |
$0.00 |